Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABAZITAXEL vs CALASPARGASE PEGOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CABAZITAXEL vs CALASPARGASE PEGOL: Safety Overview

Metric CABAZITAXEL CALASPARGASE PEGOL
Total FAERS Reports 2,553 125
Deaths Reported 467 22
Death Rate 18.3% 17.6%
Hospitalizations 950 79
Average Patient Age 68.7 yrs 11.3 yrs
% Female Patients 2.0% 50.0%
FDA Approval Date Dec 29, 2021 N/A
Manufacturer Sanofi-Aventis U.S. LLC Servier Pharmaceuticals LLC
Route N/A INTRAVENOUS
Marketing Status Prescription N/A